This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 4 EPO patents. Top assignees: Centre Regional De Lutte Contre Le Cancer Francois Baclesse, Institut De Cancerologie De L'ouest Rene Gauducheau, Université De Caen Basse Normandie. Active years: 2019.
Company Filing History:
1 out of 2 
1 out of 1 
1 out of 13 Years Active: 2019
Title: The Innovative Contributions of Philippe Juin
Introduction
Philippe Juin is a notable inventor based in Nantes, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic compounds.
Latest Patents
Philippe Juin holds a patent for "Mcl-1 modulating compounds for cancer treatment." This invention relates to compounds of formula (I) and their therapeutic use in the treatment of cancer. His work in this area demonstrates a commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, Philippe has worked with esteemed organizations such as the Centre Régional de Lutte Contre le Cancer François Baclesse and Université de Caen Basse Normandie. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Philippe has collaborated with talented individuals, including Grégory Burzicki and Jana Sopkova-de Oliveira Santos. These partnerships have enriched his work and fostered a collaborative environment for innovation.
Conclusion
Philippe Juin's contributions to cancer treatment through his patented compounds highlight his dedication to medical innovation. His work continues to inspire advancements in the field and offers hope for improved therapies for cancer patients.